Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Biological Therapy for Rheumatoid Arthritis - ppt download
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rituximab mode of action: apoptosis and ADCC. Rituximab mediated... | Download Scientific Diagram
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Empowering Targeted Therapy: Lessons from Rituximab | Science's STKE
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
PV | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar | Immunotherapy
Rituximab for the treatment of multiple sclerosis: a review | SpringerLink
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Rituximab - Wikipedia
Rituximab - Wikipedia
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Rituximab-related Severe Toxicity | SpringerLink
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Internet Scientific Publications
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Rituximab in neurological disease: principles, evidence and practice | Practical Neurology
